Frederick A. Schmitt
#153,579
Most Influential Person Now
Frederick A. Schmitt's AcademicInfluence.com Rankings
Frederick A. Schmittphilosophy Degrees
Philosophy
#8591
World Rank
#12001
Historical Rank
Logic
#5624
World Rank
#7036
Historical Rank
Frederick A. Schmittbiology Degrees
Biology
#11662
World Rank
#15074
Historical Rank
Neuroscience
#1906
World Rank
#1962
Historical Rank
Download Badge
Philosophy Biology
Frederick A. Schmitt's Degrees
- PhD Neuroscience University of California, San Diego
- Doctorate Medicine University of California, San Diego
Why Is Frederick A. Schmitt Influential?
(Suggest an Edit or Addition)Frederick A. Schmitt's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Memantine in moderate-to-severe Alzheimer's disease. (2003) (923)
- Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment (2006) (846)
- Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment (2007) (695)
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease (2009) (621)
- Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. (1997) (592)
- Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models (2014) (569)
- Alzheimer neuropathologic alterations in aged cognitively normal subjects. (1999) (543)
- Evidence of increased oxidative damage in subjects with mild cognitive impairment (2005) (536)
- Neuropathologic substrate of mild cognitive impairment. (2006) (471)
- Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. (1988) (369)
- Age and gender effects on human brain anatomy: A voxel-based morphometric study in healthy elderly (2007) (299)
- Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) (1997) (299)
- Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies (2011) (296)
- Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity (2007) (266)
- Critical decline in fine motor hand movements in human aging. (1999) (235)
- Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations (1992) (231)
- Improving dementia care: The role of screening and detection of cognitive impairment (2013) (227)
- Low sensitivity in clinical diagnoses of dementia with Lewy bodies (2010) (227)
- Hippocampal sclerosis in advanced age: clinical and pathological features. (2011) (214)
- Modeling the Association between 43 Different Clinical and Pathological Variables and the Severity of Cognitive Impairment in a Large Autopsy Cohort of Elderly Persons (2010) (203)
- Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. (2011) (203)
- Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. (1999) (200)
- Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer’s Disease by Vitamin E and Selenium Trial (PREADViSE) (2017) (189)
- Disease-related microglia heterogeneity in the hippocampus of Alzheimer’s disease, dementia with Lewy bodies, and hippocampal sclerosis of aging (2015) (182)
- A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. (2006) (180)
- A Review of Diagnostic Techniques in the Differential Diagnosis of Epileptic and Nonepileptic Seizures (2002) (179)
- The Severe Impairment Battery: Concurrent Validity and the Assessment of Longitudinal Change in Alzheimer's Disease (1997) (176)
- Vitamin E and all-cause mortality: a meta-analysis. (2011) (176)
- Risk factors for transitions from normal to mild cognitive impairment and dementia (2006) (169)
- Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology (2016) (167)
- Neuroinflammatory phenotype in early Alzheimer's disease (2013) (165)
- Human cerebral neuropathology of Type 2 diabetes mellitus. (2009) (161)
- Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease (2013) (156)
- Lewy Body Pathology in Normal Elderly Subjects (2009) (154)
- Modelling mini mental state examination changes in Alzheimer's disease. (2000) (153)
- Alzheimer's Disease in Down Syndrome. (2012) (149)
- Brain structural alterations before mild cognitive impairment (2007) (144)
- Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease (2005) (143)
- The loss of independence in activities of daily living: the role of low normal cognitive function in elderly nuns. (1996) (142)
- Validity and Reliability of the Alzheimer's Disease Cooperative Study‐Clinical Global Impression of Change (2017) (139)
- University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. (2012) (133)
- PART, a distinct tauopathy, different from classical sporadic Alzheimer disease (2015) (131)
- Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. (1990) (125)
- “New Old Pathologies”: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS) (2016) (123)
- Acceleration of HIV dementia with methamphetamine and cocaine (2011) (120)
- Determining the Competency of Alzheimer Patients to Consent to Treatment and Research (1994) (120)
- Rey-Osterrieth complex figure: Psychometric characteristics in a geriatric sample (1991) (116)
- Spectral and complexity analysis of scalp EEG characteristics for mild cognitive impairment and early Alzheimer's disease (2014) (116)
- Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. (2012) (109)
- Women at risk for AD show increased parietal activation during a fluency task (2002) (108)
- Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease. (2014) (107)
- Association between male gender and cortical Lewy body pathology in large autopsy series (2010) (105)
- Long-term cognitive impact of anticholinergic medications in older adults. (2006) (97)
- Self-reported memory complaints (2014) (97)
- Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE (2003) (96)
- Alzheimer's disease, dental amalgam and mercury. (1999) (96)
- Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. (2014) (95)
- Brains With Medial Temporal Lobe Neurofibrillary Tangles But No Neuritic Amyloid Plaques Are a Diagnostic Dilemma But May Have Pathogenetic Aspects Distinct From Alzheimer Disease (2009) (94)
- Should older adults be screened for dementia? It is important to screen for evidence of dementia! (2007) (92)
- Cluster analysis of normal personality traits in patients with psychogenic nonepileptic seizures (2005) (92)
- Assessing Utility of Single Photon Emission Computed Tomography (SPECT) Scan in Alzheimer Disease: Correlation with Cognitive Severity (1990) (92)
- Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease (2010) (91)
- Neuropsychologic impairment in adult bone marrow transplant candidates (1992) (89)
- Neuroimaging correlates of HIV-associated BBB compromise (2004) (88)
- APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis (2013) (87)
- Does the arousal system contribute to near death experience? (2006) (87)
- Outcomes after diagnosis of mild cognitive impairment in a large autopsy series (2017) (86)
- Should older adults be screened for dementia? (2006) (85)
- Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration. (2014) (83)
- Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018. (2002) (82)
- The HIV Dementia Scale: Predictive power in mild dementia and HAART (2007) (81)
- Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project. (2001) (81)
- Brain pathologies in extreme old age (2016) (78)
- Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment (2010) (76)
- Modeling the time-course of Alzheimer dementia (2001) (76)
- Frontal white matter integrity in adults with Down syndrome with and without dementia (2014) (73)
- Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults. (2020) (72)
- ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology (2014) (72)
- A Multicenter Evaluation of New Treatment Efficacy Instruments for Alzheimer's Disease Clinical Trials: Overview and General Results (1997) (71)
- Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment (2009) (71)
- Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals (2017) (70)
- Activities of Daily Living in Moderate-to-Severe Alzheimer Disease: An Analysis of the Treatment Effects of Memantine in Patients Receiving Stable Donepezil Treatment (2006) (70)
- Sleep-disordered breathing in the healthy elderly. Clinically significant? (1992) (70)
- A practical algorithm for managing Alzheimer's disease: what, when, and why? (2015) (69)
- Preclinical AD Workgroup staging: pathological correlates and potential challenges (2012) (69)
- Designing a Brief Alzheimer Screen (BAS). (2003) (67)
- Plasma amyloid-β as a function of age, level of intellectual disability, and presence of dementia in Down syndrome. (2011) (67)
- Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease (2015) (67)
- Self-Reported Head Injury and Risk of Late-Life Impairment and AD Pathology in an AD Center Cohort (2013) (66)
- Cognitive Response to Memantine in Moderate to Severe Alzheimer Disease Patients Already Receiving Donepezil: An Exploratory Reanalysis (2006) (66)
- The emotional ramifications of unmet need in dementia caregiving (2004) (66)
- MRI Temporal Lobe Volume Measures and Neuropsychologic Function in Alzheimer's Disease (1999) (63)
- Dependence as a unifying construct in defining Alzheimer's disease severity (2010) (62)
- Sleep Apnea: Prevalence of Risk Factors in a General Population (1989) (61)
- A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. (2006) (61)
- Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain (2009) (58)
- Performance of Patients with Epilepsy or Psychogenic Non-Epileptic Seizures on Four Measures of Effort (2006) (58)
- Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia (2011) (58)
- Predicting Intellectual Level from the Mini—Mental State Examination (1988) (56)
- Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes. (2012) (56)
- Sugihara causality analysis of scalp EEG for detection of early Alzheimer's disease (2014) (55)
- White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults (2014) (54)
- Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil* (2007) (54)
- Brain arteriolosclerosis (2020) (53)
- Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease. (2015) (53)
- Pharmacokinetics, Pharmacodynamics, and Safety of Metrifonate in Patients with Alzheimer's Disease (1998) (53)
- Baseline subjective memory complaints associate with increased risk of incident dementia: the PREADVISE trial. (2015) (51)
- Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease. (2000) (51)
- The New Adult Reading Test-Revised: accuracy in estimating WAIS-R IQ scores obtained 3.5 years earlier from normal older persons. (1994) (50)
- A systematic review of assessment and treatment of moderate to severe Alzheimer's disease. (2006) (50)
- A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial. (2012) (50)
- Synapse stability in the precuneus early in the progression of Alzheimer's disease. (2013) (49)
- Mild Cognitive Impairment: Statistical Models of Transition Using Longitudinal Clinical Data (2012) (49)
- An investigation of anosognosia following traumatic head injury (1990) (49)
- Designing a large prevention trial: statistical issues (2004) (49)
- Specific Functional Effects of Memantine Treatment in Patients with Moderate to Severe Alzheimer’s Disease (2004) (48)
- Cerebrovascular pathology in Down syndrome and Alzheimer disease (2017) (48)
- Temporal quantification of Alzheimer's disease severity: 'time index' model. (1995) (48)
- Clinical Evaluation of Global Change in Alzheimer's Disease: Identifying Consensus (1996) (47)
- "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction? (2011) (47)
- Measuring cognition in advanced Alzheimer's disease for clinical trials. (2002) (47)
- Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition. (2011) (47)
- The impact of caregiver executive skills on reports of patient functioning. (2008) (46)
- Shared random effects analysis of multi‐state Markov models: application to a longitudinal study of transitions to dementia (2007) (46)
- Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome. (2016) (45)
- Revised Memory and Behavior Problems Checklist (1997) (45)
- Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease. (2014) (44)
- Geriatric sleep apnea syndrome: a preliminary description. (1990) (43)
- Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease (2016) (43)
- Out-of-body experience and arousal (2007) (42)
- Frontal lobe phosphorus metabolism and neuropsychological function in aging and in alzheimer's disease (1995) (42)
- Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's disease (2016) (42)
- A Comparison of MMPI-2 Decision Rules in the Diagnosis of Nonepileptic Seizures (2003) (41)
- Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease (2000) (40)
- Clinical Features of Mild Cognitive Impairment Differ in the Research and Tertiary Clinic Settings (2008) (40)
- Findings from the National Memory Screening Day Program (2015) (40)
- ADCS Prevention Instrument Project: ADCS-Clinicians' Global Impression of Change Scales (ADCS-CGIC), Self-rated and Study Partner-rated Versions (2006) (39)
- Telephone-Assessed Mental State. (1993) (38)
- Sleep-disordered breathing in healthy aged persons: possible daytime sequelae. (1987) (38)
- Hippocampal Sclerosis but Not Normal Aging or Alzheimer Disease Is Associated With TDP-43 Pathology in the Basal Forebrain of Aged Persons (2016) (38)
- Secondary dementia caregiving and its consequences (2003) (38)
- Challenges and Considerations Related to Studying Dementia in Blacks/African Americans. (2017) (37)
- Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease (2018) (37)
- Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery (2014) (34)
- Sleep-disordered breathing in healthy aged persons: two- and three-year follow-up. (1994) (32)
- Self report on sleep symptoms in older adults: correlates of daytime sleepiness and health. (1996) (32)
- The Neurobehavioral Cognitive Status Examination: psychometric properties in use with psychiatric inpatients. (1993) (32)
- Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia. (2013) (32)
- Practice effects in a longitudinal, multi-center Alzheimer’s disease prevention clinical trial (2012) (32)
- Self-reported memory complaints: A comparison of demented and unimpaired outcomes (2015) (32)
- Efficacy of Rivastigmine on Executive Function in Patients with Parkinson's Disease Dementia (2010) (32)
- Longitudinal Functional Alterations in Asymptomatic Women at Risk for Alzheimer's Disease (2005) (30)
- Short- and Long-Term Implicit Memory in Aging and Alzheimer's Disease (2006) (30)
- Relationship of Indicators of Neuropathology, Psychopathology, and Effort to Neuropsychological Results in Patients with Epilepsy or Psychogenic Non-epileptic Seizures (2006) (29)
- CERAD practice effects and attrition bias in a dementia prevention trial (2013) (29)
- Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature (2015) (29)
- A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer’s disease (2007) (28)
- Risk of incident clinical diagnosis of Alzheimer's disease–type dementia attributable to pathology-confirmed vascular disease (2017) (28)
- Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB. (2009) (28)
- Alzheimer’s Biomarkers are Correlated with Brain Connectivity in Older Adults Differentially during Resting and Task States (2016) (28)
- Comparison of Recruitment Efforts Targeted at Primary Care Physicians Versus the Community at Large for Participation in Alzheimer Disease Clinical Trials (2010) (27)
- Neurobehavioral outcomes in diseases of childhood. Individual change models for pediatric human immunodeficiency viruses. (1991) (27)
- Evaluating Rivastigmine in Mild-to-Moderate Parkinson’s Disease Dementia Using ADAS-Cog Items (2010) (27)
- Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms (2016) (26)
- Manganese and Copper-Zinc Superoxide Dismutases in the Human Olfactory Mucosa: Increased Immunoreactivity in Alzheimer's Disease (1996) (25)
- Self‐Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial (2016) (24)
- Down syndrome, beta-amyloid and neuroimaging. (2018) (24)
- Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses (2011) (24)
- Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome (2020) (24)
- Assessing the Discriminant Ability, Reliability, and Comparability of Multiple Short Forms of the Boston Naming Test in an Alzheimer's Disease Center Cohort (2015) (24)
- Distinct patterns of default mode and executive control network circuitry contribute to present and future executive function in older adults (2019) (24)
- Stability of intelligence and intellectual predictors in older persons (1996) (23)
- Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI (2019) (23)
- Why Physicians Need to Become More Proficient in Assessing Their Patients' Competency and How They Can Achieve This (2000) (22)
- Characteristics and Performance of a Modified Version of the ADCS-CGIC CIBIC+ for Mild Cognitive Impairment Clinical Trials (2009) (22)
- A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging (2017) (22)
- Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy (2020) (21)
- Objective evaluation of personality and psychopathology in temporal lobe versus extratemporal lobe epilepsy (2010) (21)
- Seizures in Patients Receiving Concomitant Antimuscarinics and Acetylcholinesterase Inhibitor (1998) (20)
- Alzheimer's disease and head circumference. (2006) (20)
- Attitudes toward advance care planning among persons with dementia and their caregivers (2019) (20)
- A Brief Instrument to Assess Treatment Response in the Patient With Advanced Alzheimer Disease (2009) (20)
- The Statistical Modeling of Aging and Risk of Transition Project: Data Collection and Harmonization Across 11 Longitudinal Cohort Studies of Aging, Cognition, and Dementia. (2015) (20)
- Neurodegenerative memory disorders: a potential role of environmental toxins. (2005) (20)
- Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease (2011) (19)
- Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease. (2019) (19)
- Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan (2017) (18)
- Methodologic issues in neuropsychological research with HIV-spectrum disease (1993) (18)
- Visual Arts Education improves self-esteem for persons with dementia and reduces caregiver burden: A randomized controlled trial (2019) (17)
- The characteristics of dementia caregiving onset (2003) (17)
- Reviews: Effects of Transdermal Rivastigmine on ADAS-Cog Items in Mild-to-Moderate Alzheimer’s Disease (2010) (17)
- Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis (2018) (17)
- Multicenter Evaluation of New Instruments for Alzheimer's Disease Clinical Trials: Summary of Results (1997) (16)
- The Effect of Vascular Neuropathology on Late-life Cognition: Results from the SMART Project. (2016) (16)
- Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study (2021) (16)
- Psychological Profile of Somatizing Patients Attending the Integrative Clinic (1992) (16)
- Cognitive mental status examinations. (1989) (15)
- Methodologic issues in neuropsychological research with HIV-spectrum disease. (1993) (15)
- The relationship between neuropsychological impairment in alcoholics and treatment outcome at one year. (1989) (15)
- Diagnosis of Alzheimer's disease. (1996) (15)
- Unit analysis of prose memory in clinical and elderly populations (1986) (14)
- Dopaminergic modulation of memory and affective processing in Parkinson depression (2013) (13)
- INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol (2019) (13)
- Meta-Analysis of Cognition in Parkinson’s Disease Mild Cognitive Impairment and Dementia Progression (2021) (13)
- Sleep quality and pulmonary function in the healthy elderly. (1989) (13)
- Concomitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: impact on cognitive and physical functioning in Alzheimer disease. (2007) (13)
- Age-Expanded Normative Data for the Ruff 2&7 Selective Attention Test: Evaluating Cognition in Older Males (2012) (12)
- Differential Reports of Pain and Depression Differentiate Mild Cognitive Impairment From Cognitively Intact Elderly Participants (2012) (12)
- Sleep-disordered breathing in healthy aged persons: one-year follow-up of daytime sequelae. (1989) (12)
- Behaviors Characteristic of Autism Spectrum Disorder in a Geriatric Cohort With Mild Cognitive Impairment or Early Dementia (2019) (12)
- Conversational Discourse in Patients with Alzheimer's Disease (1994) (11)
- A Summary Score for the Framingham Heart Study Neuropsychological Battery (2015) (11)
- Short-term neuropsychological outcome following Gamma Knife radiosurgery for arteriovenous malformations: a preliminary report. (1999) (11)
- Dopaminergic Modulation of Medial Prefrontal Cortex Deactivation in Parkinson Depression (2015) (11)
- Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer’s Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study (2021) (11)
- Neuropsychological correlates of single photon emission computed tomography (SPECT) in Alzheimer's disease. (1992) (11)
- Repeated retrieval during working memory is sensitive to amnestic mild cognitive impairment (2013) (11)
- Models of progression in AD (2001) (9)
- Convergent and discriminant validity of the Immediate Postconcussion Assessment and Cognitive Testing Battery (ImPACT) in young athletes (2019) (9)
- Antioxidants for the prevention of dementia: Overview of the preadvise trial (2005) (9)
- Hierarchical Clustering Analyses of Plasma Proteins in Subjects With Cardiovascular Risk Factors Identify Informative Subsets Based on Differential Levels of Angiogenic and Inflammatory Biomarkers (2020) (8)
- A randomized controlled Alzheimer’s disease prevention trial’s evolution into an exposure trial: The preadvise trial (2013) (8)
- Tobacco Smoking and Dementia in a Kentucky Cohort: A Competing Risk Analysis. (2019) (8)
- Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease (2021) (8)
- Cognitive and emotional changes during a simulated 686-m deep dive. (1986) (8)
- Quality of education and memory test performance in older men: the New York University Paragraph Recall Test normative data. (2013) (8)
- Comparing Clinical Profiles in Alzheimer's Disease and Parkinson's Disease Dementia (2013) (8)
- P.4.006 Long-term efficacy and safety benefits from treatment with the NMDA antagonist memantine: results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease (2003) (7)
- Development of neurocognitive disorders in HIV/AIDS (2011) (7)
- Memory-Related Frontal Brainwaves Predict Transition to Mild Cognitive Impairment in Healthy Older Individuals Five Years Before Diagnosis (2020) (7)
- A BRIEF ALZHEIMER'S SCREEN FOR CLINICAL PRACTICE (2006) (6)
- Con: are we ready to translate Alzheimer’s disease-modifying therapies to people with down syndrome? (2014) (6)
- Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement. (2022) (6)
- Longitudinal assessment of dementia measures in Down syndrome (2020) (6)
- DOWN SYNDROME: AGE-DEPENDENCE OF PIB BINDING IN POSTMORTEM FRONTAL CORTEX ACROSS THE LIFESPAN (2017) (6)
- Measuring treatment response in Alzheimer's disease clinical trials. (2005) (5)
- Genetic Risk of Alzheimer’s Disease: Three Wishes Now That the Genie is Out of the Bottle (2018) (5)
- NEUROPATHOLOGIC ALTERATIONS IN AGED COGNITIVELY “NORMAL” SUBJECTS (1998) (5)
- Advantages of the “Time-Index” Method for Measurement of Alzheimer Dementia: Assessment of Metrifonate Benefit (1997) (5)
- Functional human GRIN2B promoter polymorphism and variation of mental processing speed in older adults (2017) (4)
- Effects of repeated screening and potential impact on AD prevention trial design: The antioxidant AD prevention (PREADVISE) trial (2009) (4)
- Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology. (2022) (4)
- Four Common Late-Life Cognitive Trajectories Patterns Associate with Replicable Underlying Neuropathologies. (2021) (4)
- Diabetes mitigates the role of memory complaint in predicting dementia risk: Results from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Study. (2017) (4)
- Brain structure changes over time in normal and mildly impaired aged persons (2020) (4)
- Neurocognitive Impact of Whole Brain Radiation on Patients With Brain Metastases: Secondary Analysis of RTOG BR-0018 (2007) (4)
- Comparing the Trends of Elevated Blood Pressure in Appalachian and Non‐Appalachian Regions (2014) (4)
- Mental Component Score (MCS) from Health-Related Quality of Life Predicts Incidence of Dementia in U.S. Males (2020) (3)
- Adjusting for mortality when identifying risk factors for transitions to MCI and dementia (2013) (3)
- White matter integrity is associated with CSF markers of AD in normal adults (2014) (3)
- Assessment of Cognitive Impairment, Alzheimer’s Disease, and Other Forms of Dementia (2018) (3)
- Severe Impairment Battery: A Potential Measure for AD Clinical Trials (1997) (3)
- Spared behavioral repetition effects in Alzheimer’s disease linked to an altered neural mechanism at posterior cortex (2018) (3)
- MODULATION OF MICRORNA PATHWAYS BY GEMFIBROZIL IN PREDEMENTIA ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL (2019) (2)
- Chapter 15 – Down Syndrome (2015) (2)
- P1-375 Functional benefits of memantine treatment for patients with moderate to severe Alzhemier's disease (2004) (2)
- Common Pathogenic Mechanisms between Down Syndrome and Alzheimer's Disease: Steps toward Therapy (2018) (2)
- Cognitive and Behavioral Domains That Reliably Differentiate Normal Aging and Dementia in Down Syndrome (2021) (2)
- William R. Markesbery, MD (1932–2010) (2010) (1)
- Promoting interactions with basic scientists and clinicians: summary of the panel session. (2000) (1)
- Dual cognitive screening for dementia: Preliminary case ascertainment in the antioxidant Alzheimer's prevention (PREADViSE) trial (2012) (1)
- Alzheimer’s disease genetic susceptibility and causality: what is ApoE’s impact? (2004) (1)
- P1-315 Functional and behavioral effects of memantine in Alzheimer's disease (2004) (1)
- Comorbid subjective cognitive decline and sleep apnea significantly increase the risk of incident dementia: Results from the prevention of Alzheimer’s disease with vitamin e and selenium study (2015) (1)
- EFFICACY OF MEMANTINE ADDED TO CHOLINESTERASE INHIBITORS ON SIB BEHAVIORAL DOMAINS: POOLED POST HOC ANALYSIS OF TWO RANDOMIZED CONTROLLED TRIALS IN PATIENTS WITH MODERATE TO SEVERE AD (2018) (1)
- Single positron emission tomography (SPECT) correlates of cognitive and behavioral dysfunction in Alzheimer's disease (1992) (1)
- P1.038 Rivastigmine treatment effects and the relationship between executive function and cognition, behavior and ADLs in Parkinson's disease dementia (2009) (1)
- Conners’ Adult ADHD Rating Scale Infrequency Index Validation and Pilot Comparison of Administration Formats (2020) (1)
- FRONTAL CORTEX MICROHEMORRHAGES IN AGING ADULTS WITH DOWN SYNDROME: A POTENTIALLY IMPORTANT CONTRIBUTOR TO ALZHEIMER’S DISEASE PATHOGENESIS (2016) (1)
- Identifying dementia in Down syndrome with the Severe Impairment Battery, Brief Praxis Test and Dementia Scale for People with Learning Disabilities. (2021) (1)
- CIGARETTE SMOKING AND RISK OF DEMENTIA IN A KENTUCKY COHORT: A COMPETING RISK ANALYSIS (2018) (1)
- The Alzheimer's Disease Centers' Neuropsychological Database Initiative: A Resource for Alzheimer's Disease Prevention Trials (2002) (1)
- P4-393: Memory screening validation for Alzheimer prevention trials: The prevention of Alzheimer's disease by vitamin E and selenium (PREADVISE) study (2008) (1)
- Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome. (2021) (1)
- Disease-related microglia heterogeneity in the hippocampus of Alzheimer’s disease, dementia with Lewy bodies, and hippocampal sclerosis of aging (2015) (0)
- Comorbid Pathology in Clinical Trial Participants: Autopsy Findings and Clinical Features (2022) (0)
- Sleep- Disordered Breathing Sleep-Disordered Breathing in Healthy Aged Persons: Two- and Three-Year Follow-Up (2001) (0)
- Supplementary Materials -The Bluegrass Short-term Memory Task and Total Interdependence Measure (2016) (0)
- Comparison of neural network and logistic regression for dementia prediction: results from the PREADViSE trial (2021) (0)
- Estimating random effects in a finite Markov chain with absorbing states: application to cognitive data (2023) (0)
- Neuropsychological outcome following Gamma Knife radiosurgery for arteriovenous malformations (1997) (0)
- SEMANTIC CLUSTERING ON THE C.V.L.T.-II IS REDUCED IN COGNITIVELY INTACT OLDER ADULTS WITH AUTOPSY-CONFIRMED ALZHEIMER’S DISEASE NEUROPATHOLOGIC CHANGE (2019) (0)
- P-118 Concordance of MIS and CERAD screening in the preadvise antioxidant AD prevention trial (2007) (0)
- P3-170 Stereological assessment of hippocampal synapses in people with Alzheimer's disease and mild cognitive impairment (2004) (0)
- The Influence of Literacy on Cognitive Functioning in Unimpaired Older Adults, Mild Cognitive Impairment, and Dementia (2006) (0)
- Modeling clinical change from normal aging to MCI, dementia, and death (2005) (0)
- P4.011 Functional benefit of memantine treatment inpatients with moderate to severe Alzheimer's disease (2004) (0)
- A longitudinal study of aging and the development of Alzheimer's disease in people with Down syndrome (2012) (0)
- THE MULTIPLE SLEEP LATENCY TEST: NORMATIVE DATA IN HEALTHY AGED ADULTS (1988) (0)
- CEREBRAL AMYLOID ANGIOPATHY AND MICROHEMORRHAGES IN THE OCCIPITAL CORTEX OF AGING ADULTS WITH DOWN SYNDROME (2017) (0)
- Open-Label Extension Studies and Misinformation—Reply (2006) (0)
- Neuropsychological correlates of Single Photon Emission Tomography (SPECT) in Alzheimer's disease (1989) (0)
- Assessment of chemotherapy-induced cognitive impairment: a prospective study of the cognitive effects of platinum/taxane-based chemotherapy in gynecologic cancer patients (2021) (0)
- Microglial phenotypes in the brains of aging people with Down syndrome and Alzheimer disease (2020) (0)
- Self-reported head injury and risk of cognitive impairment and Alzheimer's-type pathology in a longitudinal Alzheimer’s disease center cohort (2013) (0)
- INAPPROPRIATE MEDICATION USE ASSOCIATED WITH LOWER COGNITIVE RESERVE IN INDIVIDUALS WITH PRE-CLINICAL ALZHEIMER’S DISEASE (2019) (0)
- Cognitive reserve among potentially inappropriate medication users with and without preclinical Alzheimer’s disease (2020) (0)
- National Academy of Neuropsychology Abstract from the 14th Annual Meeting Orlando, FL, November 3, 4, & 5, 1994Frequency and stability of symptoms of depression, anxiety, and distress in advanced HIV disease (1995) (0)
- P2-072 Antioxidant use at enrollment predicts transitions from normal to amnestic MCI and dementia (2006) (0)
- Subjective Memory Complaint and Clinical Impact (2018) (0)
- THE LIFE-DSR STUDY (2019) (0)
- Validity of the severe impairment battery, brief praxis test, and dementia questionnaire for persons with intellectual disabilities in differentiating dementia status in individuals with Down syndrome (2020) (0)
- Early-to mid-life formal training in music is associated with improved late-life semantic and episodic memory among cognitively normal older adults (2013) (0)
- P4-155: Preclinical Alzheimer's disease in a large autopsy series of longitudinally studied, cognitively normal control subjects (2008) (0)
- The Association Between Cancer and Alzheimer's-Type Neuropathology: A Community-Based Cohort Study. (2022) (0)
- P3-007 Cognitive screening in the antioxidant AD prevention (PREADVISE) trial: Concordance of MIS and CERAD (2006) (0)
- Association of metabolic syndrome and cognitive function in a population‐based cross‐sectional study of adults aged 60 years or older (2020) (0)
- Longitudinal plasma Alzheimer’s disease biomarkers in an Alzheimer’s disease research center cohort suggest pTau181 as the most reliable plasma biomarker for brain Alzheimer’s pathology (2021) (0)
- Cancer history associates with a lower burden of dementia and Alzheimer’s‐type neuropathology in autopsied research volunteers (2021) (0)
- P1-162: Mild cognitive impairment in two distinct clinical populations: Acceptance of diagnosis, medical causes, and cognitive profiles (2008) (0)
- Longitudinal plasma levels of neurofilament light in Down syndrome: A multicenter study (2020) (0)
- UCHL-1 in the pathogenesis of sporadic PD and DLB. S1-04-04 DEMENTIA WITH LEWY BODIES (2006) (0)
- Accuracy of NEO-PI-R ratings in the assessment of personality change following traumatic brain injury (1998) (0)
- Neuopathologic substrate of clinically evident, asymmetric, hippocampal atrophy in Alzheimer's disease (2013) (0)
- Meta-Analysis of Cognition in Parkinson’s Disease Mild Cognitive Impairment and Dementia Progression (2021) (0)
- Feasibility of dual‐task gait to estimate Alzheimer's related cognitive decline in Down syndrome (2020) (0)
- DETECTION OF COGNITIVE IMPAIRMENT AFTER ACUTE ISCHEMIC STROKE: VALIDATION OF BRIEF AND MORE COMPREHENSIVE COGNITIVE SCREENING INSTRUMENTS AND IMPLICATIONS FOR BEST PRACTICE (2017) (0)
- Evaluating vascular cognitive impairment and dementia due to small‐vessel disease using plasma levels of PLGF and VEGF‐A (2020) (0)
- Pain and depression in normal cognitive aging and mild cognitive impairment (2010) (0)
- DBS Plus: a clinical trial platform for combining delivery of investigational therapeutics with deep brain stimulation surgery in patients with parkinson’s disease (2021) (0)
- Acta Neuropathologica ABCC 9 gene polymorphism is associated with hippocampal sclerosis of aging pathology (2017) (0)
- Neuropathological and memory changes in transitions between normal aging, MCI, and mild Alzheimer’s disease (2005) (0)
- Alzheimer’s disease and Down syndrome (2020) (0)
- P3-159: Practice effects: Factors associated with repeated memory impairment screen scores in the antioxidant Alzheimer's disease prevention (PREADVISE) trial (2008) (0)
- Examining Instability and Reversion in the Diagnosis of Mild Cognitive Impairment (P04.207) (2012) (0)
- Self-reported memory decline predicts mild cognitive impairment and dementia (2013) (0)
- Influence of repeated assessments on the CERAD T-score, a global measure of cognition (2012) (0)
- N11 DIALING CODES FOR TELEPHONE TRAVELER INFORMATION (1998) (0)
- Ccts Scholar Presentation Abstracts the Effects of Preclinical Ad Pathology on Default-mode Network Function and Executive Performance Are Mediated by Declining White Matter Microstructure (0)
- WITHIN-SESSION LEARNING OF AN OBJECT IDENTIFICATION TASK PREDICTS ELEVATED BRAIN AMYLOID AND FUTURE TASK PERFORMANCE (2019) (0)
- Quality of life scores predict incidence of dementia: Results from PREADViSE (2020) (0)
- Frequency and stability of symptoms of depression, anxiety, and distress in advanced HIV disease (1995) (0)
- Gait and Balance Changes with Investigational Peripheral Nerve Cell Therapy during Deep Brain Stimulation in People with Parkinson’s Disease (2021) (0)
- Speed and memory correlates of digit symbol recall performance in older adults (1997) (0)
- Reduced rank multinomial logistic regression in Markov chains with application to cognitive data (2021) (0)
- P.5.a.009 Memantine treatment in a trial of patients with moderate to severe Alzheimer's disease: response across multiple domains (2007) (0)
- Primitive Reflexes and Dementia in Adults With Down Syndrome. (2021) (0)
- Evaluation of personality change following traumatic brain injury using the NEO-PI-R (1997) (0)
- P1-002 Robust response to memantine treatment when functional and behavioral efficacies are combined with cognition (2004) (0)
- Frontal Release Signs in Adults with Down Syndrome Are Associated with Dementia (P3.198) (2014) (0)
- ASSOCIATIONS BETWEEN TDP-43 PROTEINOPATHY AND COGNITIVE TEST SCORES IN NON-FTLD OLDER ADULTS (2019) (0)
- Aging 1-2018 Down Syndrome , Beta-Amyloid and Neuroimaging (2019) (0)
- Contents Vol. 37, 2014 (2014) (0)
- P4-158: Preservation of synaptic numbers in the precuneus associated with mild cognitive impairment and mild-to-moderate Alzheimer's disease (2008) (0)
- Author Response. (2015) (0)
- Frontal Release Signs Predict Decline in Subjects with Intact Cognition and Mild Cognitive Impairment (P01.082) (2012) (0)
- Preclinical Alzheimer's disease cannot be reliably identified in the antemortem setting using standard clinical and neuropsychological test measures (2009) (0)
- Potentially inappropriate medication use associated with lower mobility reserve among individuals with preclinical Alzheimer’s disease (2020) (0)
- Cerebrovascular pathology in Down syndrome and Alzheimer disease (2017) (0)
- Type 2 diabetes and cognitive status: A causal inference approach to estimate effects (2020) (0)
- In Vivo Brain Imaging in Down Syndrome: Functional and Structural Similarities with Alzheimer’s Disease (2015) (0)
- ASSESSMENT OF PLASMA AND CSF FOR ANGIOGENIC AND INFLAMMATORY PROTEINS IN A CLINICAL COHORT OF PATIENTS WITH VASCULAR COGNITIVE IMPAIRMENT AND DEMENTIA REVEAL POTENTIAL BIOMARKERS OF DISEASE SEVERITY (2019) (0)
- Excess Synaptojanin 1 Co ntributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer ’ s Disease Graphical Abstract Highlights (0)
- A Brief Alzheimer’s screen for Use in clinical practice (2005) (0)
- AGING IN DOWN SYNDROME: AGE-ASSOCIATED BRAIN METABOLITE CHANGES (2019) (0)
- An Introduction to Neuropsychology and Aging. (1994) (0)
- Care Planning for Individuals with Dementia Survey (2020) (0)
- Caregiver Unmet Need Questionnaire (2013) (0)
- Does targeted medication therapy management increase cognitive reserve? Results from the INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE) study (2021) (0)
- Minority Participation in the PREADVISE Trial: Relevant Characteristics (2006) (0)
- P4.028 Functional and behavioral effects of memantinein Alzheimer's disease (2004) (0)
- Open-label extension studies and misinformation. Author's reply (2006) (0)
- A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging (2017) (0)
- Clinical correlates of hippocampal sclerosis of aging: The University of Kentucky experience (2013) (0)
- Cognition, Aging, and the Development of Dementia in Down Syndrome (2019) (0)
- LOSSES IN FRONTAL WHITE MATTER INTEGRITY IN ADULTS WITH DOWN SYNDROME WITH AND WITHOUT DEMENTIA (2014) (0)
- Vascular neuropathology in dementia patients receiving antipsychotic therapy (2013) (0)
- A-101 Correspondence between ABAS-II and VABS-II Composite Scales in a Cohort of Adults with Down Syndrome (2022) (0)
- INTERVENTION FOR COGNITIVE RESERVE ENHANCEMENT IN DELAYING THE ONSET OF ALZHEIMER’S SYMPTOMATIC EXPRESSION (INCREASE) STUDY- PROTOCOL AND BASELINE EVALUATION OF PARTICIPANTS (2019) (0)
- O1-01-01 Synaptic alterations in inferior temporal lobe in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI) (2006) (0)
- CSF MARKERS OF PRECLINICAL ALZHEIMER'S AND DEFICITS ON A SELF-ADMINISTERED COMPUTERIZED TEST BATTERY (2018) (0)
- Alzheimer’s Disease‐Related Polygenic Risk Score Profiles and Brain Proteinopathies (2022) (0)
- IC-P-040 Structural image data from normals grouped by six-year cognitive outcome: MCI/AD conversion vs. normal (2006) (0)
- P4.021 Robust response to memantine treatmentwhen functional and behavioral results are combined with cognition (2004) (0)
- Determination of epileptic versus non-epileptic seizures using clinical symptoms and the MMPI-2 (2000) (0)
- Foreword (0)
- The Effectiveness of Community-based Outreach Events for the Promotion of African American Research Participation (2020) (0)
- Antipsychotic Use Is Not Associated with an Increased Burden of Cerebrovascular Pathology at Autopsy (S04.004) (2012) (0)
- ALZHEIMER ’ S SCREEN FOR CLINICAL PRACTICE (2006) (0)
- A meta‐analysis of neurocognition in mild cognitive impairment in Parkinson’s disease and progression to Parkinson’s disease dementia (2020) (0)
- SIB MAINTENANCE OF RESPONSE WITH MEMANTINE ADDED TO CHOLINESTERASE INHIBITORS: POOLED POST HOC ANALYSIS OF 2 RANDOMIZED CONTROLLED TRIALS IN PATIENTS WITH MODERATE TO SEVERE AD (2018) (0)
- PROGNOSIS OF CONVERSION TO MILD COGNITIVE IMPAIRMENT AND TIME TO RELIABLE CHANGES VIA MEMORY-RELATED ELECTROPHYSIOLOGICAL BRAIN SIGNATURES (2019) (0)
- P-200 Factors associated with practice effects and decline in MIS scores in the preadvise antioxidant Alzheimer’s disease prevention trial (2007) (0)
- Assessment of chemotherapy-induced cognitive impairment: A prospective study of the biochemical and metabolic effects of platinum/taxane-based chemotherapy in gynecologic cancer patients. (2021) (0)
- PROGNOSIS OF CONVERSION TO MILD COGNITIVE IMPAIRMENT AND TIME TO STABLE CHANGES VIA MEMORY-RELATED ELECTROPHYSIOLOGICAL BRAIN SIGNATURES (2019) (0)
- Periodic Movements of Sleep (Nocturnal Myoclonus) in Healthy Aged Adults (1988) (0)
- Medication‐related problems in older adults with and without preclinical Alzheimer’s disease: A baseline description from the INCREASE study (2020) (0)
- List of contributors. (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Frederick A. Schmitt?
Frederick A. Schmitt is affiliated with the following schools:
